Live News EQUITY FLASH L impact Nov 05, 2026, 12:05 PM UTC Peptilogics Enrolls First International Patient in Phase 2/3 Trial The RETAIN trial of zaloganan for prosthetic joint infection has added UK trial sites. SquawkNews Desk